Catalog Peptide Custom Syntheses
2001
Aug-2001 Found
2004
July-2004 1st Building 2800㎡
Rapid Diagnosis
2005
Aug-2005 ISO9001
2006
cGMP-
CFDA certification
2008
ISO13485
- cGMP Audits
- EHS
- g-500g API
- FTE
- Peptide Design
2009
Leuprolide PAI
2010
2nd Building expand 1860㎡
2011
1st FDA Visit No 483
- g-2Kg API
- More 510K
2012
2nd FDA Visit No 483
Lilly Venture
2014
3rd Building expand 14865㎡
3rd FDA Visit No 483
2016
4th FDA Visit No 483
New campus 70,000㎡
2017
Triptorelin DMF
Exenatide DMF